Consumers Take Proactive Approach with Immune Health Dietary Supplements

More consumers than ever before are using dietary supplements and searching for immune health products.

“After the past several years, people are taking a proactive stance on their health. Instead of reacting to illnesses, they are trying to prevent health problems,” said Diana Zhabilov, CEO of Virogentics, Inc, a division of Enzolytics, Inc. (ENZC) which makes IPF Immune. “A record number of consumers are taking dietary supplements, and the global immune health industry is expected to grow by 11.3 percent annually through 2028.”

Ms. Zhabilov said people want to stay healthy, which is why they are searching for immune health supplements.

“We developed IFP Immune to help people maintain their body’s natural immune function,” she said. “Without a strong immune system, people realize they can’t have a high quality of life.

“Enzolytics, through Virogentics, wants to help people live their lives to the fullest,” Mr. Cotropia, CEO of Enzolytics, Inc. said. “IPF Immune gives our body’s self-defense system a helping hand.”

Virogentics, Inc. has already launched IPF Immune in the United States, where it is available on Amazon, where it sold out its first shipment, Walmart.com, and OneLavi.com.

“We are promoting IPF Immune to consumers and retailers in the U.S.,” he added. “Consumers understand that our product is a natural, proprietary formula supported by science.”

Harry H. Zhabilov, Enzolytics’ Chief Scientific Officer, said IPF Immune helps keep the immune system working optimally.

“With our dietary supplement, our immune system is ready to quickly and efficiently keep you healthy and feeling good,” he added.

Gluten-free IPF Immune is a nutritional supplement taken orally two days in a row per week for eight consecutive weeks. Enzolytics is a Texas-based biotechnology company committed to developing effective and affordable therapeutics for treating various conditions.

To purchase IPF Immune, please visit Amazon, Walmart.com, and OneLavi.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Virogentics, Inc. or Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:
Virogentics, Inc.
1101 Raintree Circle, Suite 130
Allen, Texas 75013

And

Research Center
Enzolytics, Inc.
Texas A&M University
Institute for Preclinical Studies
College Station, TX 77843-44

SOURCE: Enzolytics, Inc.

About VIROGENTICS, INC.

Virogentics, Inc. is a division of Enzolytics, Inc. (ENZC), which makes IPF Immune. Enzolytics Inc. is a Texas-located biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to IPF Immune, Enzolytics is developing other therapeutics for treating multiple infectious diseases.